Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cg Oncology Inc (CGON)

Cg Oncology Inc (CGON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cg Oncology Inc 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 USA

https://cgoncology.com Employees: 113 P: 949-409-3700

Sector:

Medical

Description:

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology is based in IRVINE, Calif.

Key Statistics

Overview:

Market Capitalization, $K 4,414,851
Enterprise Value, $K 4,157,781
Shares Outstanding, K 80,666
Float, K 74,697
% Float 92.60%
Short Interest, K 13,145
Short Float 16.30%
Days to Cover 17.44
Short Volume Ratio 0.50
% of Insider Shareholders 7.40%
% of Institutional Shareholders 26.56%

Financials:

Annual Sales, $ 1,140 K
Annual Net Income, $ -88,040 K
Last Quarter Sales, $ 1,670 K
Last Quarter Net Income, $ -43,810 K
EBIT, $ -180,120 K
EBITDA, $ -185,080 K

Growth:

1-Year Return 88.08%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.57 on 11/14/25
Next Earnings Date 03/27/26
Earnings Per Share ttm -2.04
EPS Growth vs. Prev Qtr -5.56%
EPS Growth vs. Prev Year -90.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CGON Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -21.67%
Return-on-Assets % -20.79%
Profit Margin % -7,722.81%
Debt/Equity 0.00
Price/Sales 1,876.81
Price/Cash Flow N/A
Price/Book 5.88
Book Value/Share 9.02
Interest Coverage -1.61
60-Month Beta 1.35
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar